Accordingly, the coagulopathy of COVID-19, typically defined by hypercoagulation associated with elevations in D-dimer and FDPs with mild thrombocytopenia and prolonged prothrombin time, may be distinct from DIC and likely reflects dysregulated hemostasis.124. Here, F2 is linked to COVID-19.